Authors: BEVERIDGE R SCHUSTER M WALLER E STUART R ABBOUD C CRUICKSHANK S MENCHACA D MACRI M CONNAGHAN DG

Citation: R. Beveridge et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)IN BREAST-CANCER PATIENTS (PTS) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Blood, 90(10), 1997, pp. 2580-2580

Authors: CRAIG JR BAIN VG BLACK M CRUICKSHANK S EHRINPREIS M FOUST R HOFLING D LEE W SAROSI I SMITH CI VANLEEUWEN DJ

Citation: Jr. Craig et al., LIVER HISTOLOGY IMPROVEMENT IS ASSOCIATED WITH ALT AND HCV RNA RESPONSE FOLLOWING TREATMENT WITH CONSENSUS INTERFERON (CIFN), Gastroenterology, 110(4), 1996, pp. 1175-1175

Authors: MAHER DW LIESCHKE GJ GREEN M BISHOP J STUARTHARRIS R WOLF M SHERIDAN WP KEFFORD RF CEBON J OLVER I MCKENDRICK J TONER G BRADSTOCK K LIESCHKE M CRUICKSHANK S TOMITA DK HOFFMAN EW FOX RM MORSTYN G

Citation: Dw. Maher et al., FILGRASTIM IN PATIENTS WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 121(7), 1994, pp. 492-501